Company intelligence / Profile preview

Promedico

Petah Tikva, Center District, Israel

Ownership: Private
Employees: ~311
Development stage: Other

Overview

Promedico is Israel’s leading pharma supply chain provider, distributing pharmaceuticals, biologics, vaccines, medical devices, dietary supplements, and more to hospitals, pharmacies, clinics, research institutions, and retail; handles over 25,000 deliveries monthly, including highly sensitive specialty and radio-pharmaceuticals

Modalities: Small moleculeBiologicsVaccineRadiopharmaceutical
Industry: Drug Discovery Services

Partnerships

Karyopharm Therapeutics (exclusive distributor for XPOVIO®/selinexor in Israel and Palestinian Authority)Other pharma, device, and global consumer health partnerships (undisclosed specifics)

Beyond the preview

Go deeper on Promedico.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Promedico.

Explore the full profile